DORAYA-HF Early Feasibility Study

Running, not enrolling · Not applicable

Conditions studied: Acute Decompensated Heart Failure

In brief

The study objective is to evaluate the feasibility of the Doraya Catheter and measure clinical performance and safety endpoints, in ADHF patients deemed to have insufficient diuretic response.

Key facts

Study ID

NCT05206422

Run by

Revamp Medical Inc.

People needed

30

Starts

2022-10-05

Expected to finish

2026-03-31

Last updated by the study team

2026-03-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Zuckerberg San Francisco General — San Francisco, California, United States
• San Francisco VA — San Francisco, California, United States
• UCSF — San Francisco, California, United States
• Cleveland Clinic — Weston, Florida, United States
• Piedmont Hospital — Augusta, Georgia, United States
• Northeast Georgia Medical Center — Gainesville, Georgia, United States
• Christian Hospital — St Louis, Missouri, United States
• The Christ Hospital — Cincinnati, Ohio, United States
• The MetroHealth System — Cleveland, Ohio, United States
• The Ohio State University — Columbus, Ohio, United States
• Oklahoma Heart — Oklahoma City, Oklahoma, United States
• Prisma Health — Columbia, South Carolina, United States
• Baylor University Medical Center — Dallas, Texas, United States
• CHI St. Luke's Health-Baylor St. Luke's Medical Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.